Annual Statements Open main menu

Genasys Inc. - Quarter Report: 2012 December (Form 10-Q)

Form 10-Q

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark one)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2012

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                          to                          .

Commission File Number: 000-24248

 

 

 

LOGO

LRAD CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   87-0361799

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

16990 Goldentop Rd. Ste. A, San Diego,

California

  92127
(Address of principal executive offices)   (Zip Code)

(858) 676-1112

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes    ¨  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    x  Yes    ¨  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)    Smaller reporting company   x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    ¨  Yes  x    No

The number of shares of Common Stock, $0.00001 par value, outstanding on January 31, 2013 was 32,399,199.

 

 

 


PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

LRAD Corporation

CONDENSED CONSOLIDATED BALANCE SHEETS

 

     December 31,        
     2012     September 30,  
     (Unaudited)     2012  

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 16,139,078      $ 13,859,505   

Accounts receivable, less allowance of $4,172 and $4,372 for doubtful accounts

     2,268,710        5,517,894   

Inventories, net

     4,192,342        3,112,489   

Prepaid expenses and other

     356,921        441,823   
  

 

 

   

 

 

 

Total current assets

     22,957,051        22,931,711   

Property and equipment, net

     264,602        212,863   

Intangible assets, net

     148,502        158,457   

Prepaid expenses and other—noncurrent

     1,055,141        1,102,016   
  

 

 

   

 

 

 

Total assets

   $ 24,425,296      $ 24,405,047   
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable

   $ 791,406      $ 995,719   

Accrued liabilities

     722,429        623,742   
  

 

 

   

 

 

 

Total current liabilities

     1,513,835        1,619,461   

Other liabilities—noncurrent

     364,862        363,817   
  

 

 

   

 

 

 

Total liabilities

     1,878,697        1,983,278   
  

 

 

   

 

 

 

Commitments and contingencies (Note 8)

    

Stockholders’ equity:

    

Preferred stock, $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding

     —          —     

Common stock, $0.00001 par value; 50,000,000 shares authorized; 32,399,199 and 32,374,499 shares issued and outstanding, respectively

     324        324   

Additional paid-in capital

     86,583,217        86,358,011   

Accumulated deficit

     (64,036,942     (63,936,566
  

 

 

   

 

 

 

Total stockholders’ equity

     22,546,599        22,421,769   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 24,425,296      $ 24,405,047   
  

 

 

   

 

 

 

See accompanying notes

 

1


LRAD Corporation

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

     Three months ended  
     December 31,  
     2012     2011  

Revenues:

    

Product sales

   $ 2,762,345      $ 3,545,053   

Contract and other

     217,762        66,582   
  

 

 

   

 

 

 

Total revenues

     2,980,107        3,611,635   

Cost of revenues

     1,494,284        1,863,041   
  

 

 

   

 

 

 

Gross profit

     1,485,823        1,748,594   
  

 

 

   

 

 

 

Operating expenses:

    

Selling, general and administrative

     1,172,475        1,056,559   

Research and development

     421,921        381,318   
  

 

 

   

 

 

 

Total operating expenses

     1,594,396        1,437,877   
  

 

 

   

 

 

 

(Loss) income from operations

     (108,573     310,717   

Other income

     8,197        12,944   
  

 

 

   

 

 

 

(Loss) income from operations before income taxes

     (100,376     323,661   

Income tax expense

     —           9,715   
  

 

 

   

 

 

 

Net (loss) income

   $ (100,376   $ 313,946   
  

 

 

   

 

 

 

Net income per common share—basic and diluted

   $ 0.00      $ 0.01   

Weighted average common shares outstanding:

    

Basic

     32,399,199        32,374,499   
  

 

 

   

 

 

 

Diluted

     32,399,199        33,061,520   
  

 

 

   

 

 

 

See accompanying notes

 

2


LRAD Corporation

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

     Three months ended  
     December 31,  
     2012     2011  

Operating Activities:

    

Net (loss) income

   $ (100,376   $ 313,946   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     30,716        22,776   

Provision for doubtful accounts

     (200     —     

Warranty provision

     (9,445     64,310   

Inventory obsolescence

     (29,701     162,602   

Share-based compensation

     205,978        139,286   

Loss on sale or impairment of patents

     5,138        10,616   

Changes in operating assets and liabilities:

    

Accounts receivable

     3,249,384        2,358,304   

Inventories

     (1,050,152     (366,924

Prepaid expenses and other

     84,902        107,450   

Prepaid expenses—noncurrent

     46,875        15,515   

Accounts payable

     (204,313     (443,881

Warranty settlements

     (4,275     (13,095

Accrued and other liabilities

     113,452        (2,392,446
  

 

 

   

 

 

 

Net cash provided by (used in) operating activities

     2,337,983        (21,541

Investing Activities:

    

Purchase of equipment

     (76,655     (3,617

Patent costs paid

     (983     (227
  

 

 

   

 

 

 

Net cash used in investing activities

     (77,638     (3,844

Financing Activities:

    

Proceeds from exercise of stock options

     19,228        —     
  

 

 

   

 

 

 

Net cash provided by financing activities

     19,228        —     
  

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     2,279,573        (25,385

Cash and cash equivalents, beginning of period

     13,859,505        13,870,762   
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 16,139,078      $ 13,845,377   
  

 

 

   

 

 

 

Supplemental Disclosure of Cash Flow Information

    

Cash (refunded) paid for taxes

   $ (40,324   $ 50,000   
  

 

 

   

 

 

 

See accompanying notes

 

3


LRAD Corporation

Notes to Interim Condensed Consolidated Financial Statements (unaudited)

1. OPERATIONS

LRAD Corporation, a Delaware corporation (the “Company”), is engaged in the design, development and commercialization of directed sound technologies and products. The principal markets for the Company’s proprietary sound reproduction technologies and products are in North America, Europe, the Middle East and Asia.

2. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

General

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Form 10-Q and applicable sections of Regulation S-X. Certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although, in the opinion of management, the interim financial statements reflect all adjustments necessary, and disclosures included therein are adequate, in order to make the financial statements not misleading. The condensed consolidated balance sheet as of September 30, 2012 was derived from the Company’s most recent audited financial statements. Operating results for the three month period are not necessarily indicative of the results that may be expected for the year. The interim condensed financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended September 30, 2012 included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission (“SEC”) on December 4, 2012.

Principles of Consolidation

The Company has a currently inactive wholly owned subsidiary, American Technology Holdings, Inc., which the Company formed to conduct international marketing, sales and distribution activities. The condensed consolidated financial statements include the accounts of this subsidiary after elimination of intercompany transactions and accounts.

Fair Value Measurements

At December 31, 2012, there was no difference between the carrying value and fair market value of the Company’s cash equivalents. For certain financial instruments, including accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their relatively short maturities.

Reclassifications

Where necessary, the prior year’s information has been reclassified to conform to the current year presentation

3. INVENTORIES

Inventories consisted of the following:

 

     December 31,     September 30,  
     2012     2012  

Finished goods

   $ 806,750      $ 818,082   

Work in process

     163,152        61,859   

Raw materials

     3,653,944        2,693,753   
  

 

 

   

 

 

 
     4,623,846        3,573,694   

Reserve for obsolescence

     (431,504     (461,205
  

 

 

   

 

 

 
   $ 4,192,342      $ 3,112,489   
  

 

 

   

 

 

 

 

4


4. PROPERTY AND EQUIPMENT

Property and equipment consisted of the following:

 

     December 31,     September 30,  
     2012     2012  

Machinery and equipment

   $ 599,687      $ 525,020   

Office furniture and equipment

     718,613        716,625   

Leasehold improvements

     55,298        55,298   
  

 

 

   

 

 

 
     1,373,598        1,296,943   

Accumulated depreciation

     (1,108,996     (1,084,080
  

 

 

   

 

 

 
   $ 264,602      $ 212,863   
  

 

 

   

 

 

 
     Three months ended  
     December 31,  
     2012     2011  

Depreciation expense

   $ 24,916      $ 15,124   
  

 

 

   

 

 

 

5. INTANGIBLE ASSETS

Patents consisted of the following:

 

     December 31,     September 30,  
     2012     2012  

Cost

   $ 348,832      $ 358,925   

Accumulated amortization

     (200,330     (200,468
  

 

 

   

 

 

 
   $ 148,502      $ 158,457   
  

 

 

   

 

 

 
     December 31,     December 31,  
     2012     2011  

Amortization expense

   $ 5,800      $ 7,652   

Loss on sale or impairment of patents

     —          10,616   

Each quarter, the Company reviews the ongoing value of its capitalized patent costs and reduces the value if any of its patents are no longer consistent with its business strategy, as noted in the above table.

 

5


6. ACCRUED LIABILITIES AND OTHER LIABILITIES—NONCURRENT

Accrued liabilities consisted of the following:

 

     December 31,      September 30,  
     2012      2012  

Payroll and related

   $ 247,890       $ 272,212   

Accrued contract costs

     295,549         197,032   

Warranty reserve

     175,747         154,069   

Deferred revenue

     419         419   

Customer deposits

     2,824         10   
  

 

 

    

 

 

 

Total

   $ 722,429       $ 623,742   
  

 

 

    

 

 

 

Other liabilities—noncurrent consisted of the following:

 

Deferred revenue—noncurrent

   $ 270,140       $ 270,140   

Extended warranty

     14,846         50,244   

Deferred rent

     79,876         43,433   
  

 

 

    

 

 

 

Total

   $ 364,862       $   363,817   
  

 

 

    

 

 

 

Deferred Revenue

Deferred revenue at December 31, 2012 and September 30, 2012 included $270,559, collected from a license agreement in advance of recognized revenue.

Warranty Reserve

Changes in the warranty reserve during the three months ended December 31, 2012 and 2011 were as follows:

 

     Three months ended  
     December 31,  
     2012     2011  

Beginning balance

   $ 204,313      $ 272,261   

Warranty provision

     (9,445     64,310   

Warranty settlements

     (4,275     (13,095
  

 

 

   

 

 

 

Ending balance

   $ 190,593      $ 323,476   
  

 

 

   

 

 

 

Short-term warranty reserve

   $ 175,747      $ 289,200   

Long-term warranty reserve

     14,846        34,276   
  

 

 

   

 

 

 
   $ 190,593      $ 323,476   
  

 

 

   

 

 

 

7. INCOME TAXES

At December 31, 2012, the Company had federal net operating losses (“NOLs”) and related state NOLs. In accordance with Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 740, “Accounting for Income Taxes” (“ASC 740”), the Company recorded a full valuation allowance as it is more likely than not that some or all of the deferred tax assets will not be realized in the future.

The Company did not record a tax provision during the three months ended December 31, 2012 as the Company expects its annual effective tax rate to be zero. In addition to the Company’s federal NOLs, it also made an election under Section 172(b)(1)(H) of the Internal Revenue Code of 1986 (“Section 172”), as amended per the American Recovery and Reinvestment Tax Act of 2009, to carry back its fiscal year ended September 30, 2008 applicable NOL for a period of 3 years, and carry forward the loss for up to 20 years, which offsets the Alternative Minimum Tax in the current tax year. In addition, the state of California has reinstated the NOL carryover deduction for taxable years beginning on or after January 1, 2012, which are expected to offset any state taxes during the 2013 fiscal year.

 

6


ASC 740 requires the Company to recognize in its financial statements uncertainties in tax positions taken that may not be sustained upon examination by the taxing authorities. If interest or penalties are assessed, the Company would recognize these charges as income tax expense. The Company has not recorded any income tax expense or benefit for uncertain tax positions.

8. COMMITMENTS AND CONTINGENCIES

Bank and Other Cash Equivalent Deposits in Excess of FDIC Insurance Limits

The Company maintains cash and cash equivalent accounts with Federal Deposit Insurance Corporation (“FDIC”) insured financial institutions. Under provisions of the Dodd Frank Wall Street Reform and Consumer Protection Act (“Dodd Frank Act”), unlimited FDIC insurance was provided for all funds in non-interest bearing transaction accounts through December 31, 2012. In addition, certain of the Company’s interest bearing collateral money market and savings accounts are each insured up to $250,000 by the FDIC. The Company’s exposure for amounts in excess of FDIC insured limits at December 31, 2012 was approximately $13,400,000. The Company has not experienced any losses in such accounts.

Litigation

The Company may at times be involved in litigation in the ordinary course of business. The Company will, from time to time, when appropriate in management’s estimation, record adequate reserves in the Company’s financial statements for pending litigation. On July 24, 2012, the Company was served with a complaint filed in the Delaware Court of Chancery by Iroquois Master Fund Ltd., a shareholder of the Company, against the Company’s board of directors, its Chief Executive Officer and Chief Financial Officer. The action is a purported derivative action which alleges breach of fiduciary duty and other claims against the individual defendants based on the issuance of stock options to them, which plaintiff alleges were granted in violation of the terms of the Company’s 2005 Equity Incentive Plan. The Company was also named in the action as a nominal defendant against which no recovery is sought. The plaintiff seeks rescission or repricing of the stock options at issue and other damages, purportedly on behalf of the Company. The defendants filed a motion to dismiss the complaint. Rather than oppose the motion, the plaintiff filed an amended complaint on November 19, 2012. Defendants filed a motion to dismiss the amended derivative complaint on December 17, 2012 and the motion is in the process of being fully briefed to the Court. The Company and the individual defendants seek dismissal of the complaint on the grounds that Plaintiff has failed to comply with Delaware law in filing the complaint and because the Complaint fails to state a claim under law.

Bonus Plan

The Company has an incentive bonus plan for fiscal year 2013 designed to motivate its employees to achieve the Company’s financial objectives. All of the Company’s employees are entitled to participate in the incentive plan. Target Bonus Amounts (“Target”) vary based on a percentage of the employee’s base salary which range from 10% to 50% of base salary and a bonus payment may be made at three levels, including at 50% of Target, at 100% of Target and at 200% of Target, depending upon the achievement by the Company of specified earnings per share goals. Included in such calculation is the cost of the incentive plan. For purposes of the earnings per share calculation, the number of shares outstanding will also be held constant as of October 1, 2012. During the three months ended December 31, 2012 and 2011, the Company did not record any bonus expense in connection with the respective 2013 or 2012 plans.

9. SHARE-BASED COMPENSATION

Stock Option Plans

At December 31, 2012, the Company had one equity incentive plan, the 2005 Equity Incentive Plan (“2005 Equity Plan”). The 2005 Equity Plan, as amended, authorizes for issuance as stock options, stock appreciation rights, or stock awards an aggregate of 3,250,000 new shares of common stock to employees, directors or consultants. The total plan reserve includes these new shares and shares reserved under prior plans, allowing for the issuance of up to 4,999,564 shares. At December 31, 2012, there were options outstanding covering 3,353,339 shares of common stock under the 2005 Equity Plan and an additional 1,055,277 shares of common stock available for grant.

 

7


Stock Option Activity

The following table summarizes information about stock option activity during the three months ended December 31, 2012:

 

     Number     Weighted Average  
     of Shares     Exercise Price  

Outstanding October 1, 2012

     3,463,339      $ 1.31   

Granted

     500      $ 1.00   

Forfeited/expired

     (85,800   $ 1.34   

Exercised

     (24,700   $ 0.78   
  

 

 

   

Outstanding December 31, 2012

     3,353,339      $ 1.31   
  

 

 

   

Exercisable December 31, 2012

     2,604,055      $ 1.27   
  

 

 

   

Options outstanding are exercisable at prices ranging from $0.46 to $3.13 and expire over the period from 2013 to 2022 with an average life of 4.90 years. The aggregate intrinsic value of options outstanding and exercisable at December 31, 2012 was $453,844 and $453,717, respectively.

Share-Based Compensation

The Company recorded share-based compensation expense and classified it in the condensed consolidated statements of operations as follows:

 

     Three months ended  
     December 31,  
     2012      2011  

Cost of revenue

   $ 3,899       $ 6,881   

Selling, general and administrative

     189,831         118,399   

Research and development

     12,248         14,006   
  

 

 

    

 

 

 

Total

   $ 205,978       $ 139,286   
  

 

 

    

 

 

 

The employee stock option granted in the three months ended December 31, 2012 had a weighted-average estimated fair value of $.70 per share, using the Black-Scholes option pricing model with the following weighted-average assumptions (annualized percentages):

 

     Three months ended  
     December 31,  
     2012     2011  

Volatility

     81.0     na   

Risk-free interest rate

     0.9     na   

Forfeiture rate

     10.0     na   

Dividend yield

     0.0     na   

Expected life in years

     6.4        na   

Weighted average fair value of options granted during the period

   $ 0.70        na   

There were no stock options granted during the three months ended December 31, 2011. The Company has never paid cash dividends and has no present intention to pay cash dividends. Expected volatility is based on the historical volatility of the Company’s common stock over the period commensurate with the expected life of the options. The risk-free interest rate is based on rates published by the Federal Reserve Board. The expected life is based on observed and expected time to post-vesting exercise. The expected forfeiture rate is based on past experience and employee retention data. Forfeitures are estimated at the time of the grant and revised in subsequent periods if actual forfeitures differ from those estimates or if the Company updates its estimated forfeiture rate. Such amounts will be recorded as a cumulative adjustment in the period in which the estimate is changed.

Since the Company has an NOL carryforward as of December 31, 2012, no excess tax benefit for the tax deductions related to share-based awards was recognized for the three months ended December 31, 2012 and 2011. As of December 31, 2012, there was approximately $900,000 of total unrecognized compensation cost related to non-vested share-based employee compensation arrangements. The cost is expected to be recognized over a weighted-average period of 1.5 years.

 

8


10. STOCKHOLDERS’ EQUITY

Summary

The following table summarizes changes in the components of stockholders’ equity during the three months ended December 31, 2012:

 

            Additional            Total  
     Common Stock      Paid-in      Accumulated     Stockholders’  
     Shares      Amount      Capital      Deficit     Equity  

Balances, September 30, 2012

     32,374,499       $ 324       $ 86,358,011       $ (63,936,566   $ 22,421,769   

Issuance of common stock upon exercise of stock options

     24,700       $ —         $ 19,228       $ —        $ 19,228   

Share-based compensation expense

     —            —            205,978         —           205,978   

Net loss

     —            —            —           (100,376     (100,376
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Balances, December 31, 2012

     32,399,199       $ 324       $ 86,583,217       $ (64,036,942   $ 22,546,599   
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Stock Purchase Warrants

At December 31, 2012, the Company had 1,627,945 shares purchasable under outstanding warrants at an exercise price of $2.67 which are exercisable through February 4, 2016.

11. INCOME (LOSS) PER SHARE

The following table sets forth the computation of basic and diluted earnings per share:

 

     Three Months Ended  
     December 31,  
     2012     2011  

Basic

    

(Loss) income available to common stockholders

   $ (100,376   $ 313,946   
  

 

 

   

 

 

 

Weighted average common shares outstanding

     32,399,199        32,374,499   
  

 

 

   

 

 

 

Basic income per common share

   $ 0.00      $ 0.01   
  

 

 

   

 

 

 

Diluted

    

(Loss) income available to common stockholders

   $ (100,376   $ 313,946   
  

 

 

   

 

 

 

Weighted average common shares outstanding

     32,399,199        32,374,499   

Assumed exercise of dilutive options and warrants

     0        687,021   
  

 

 

   

 

 

 

Weighted average dilutive shares outstanding

     32,399,199        33,061,520   
  

 

 

   

 

 

 

Diluted income per common share

   $ 0.00      $ 0.01   
  

 

 

   

 

 

 

Potentially dilutive securities outstanding at period end excluded from the diluted computation as the inclusion would have been antidilutive:

    

Options

     2,617,857        2,647,700   

Warrantss

     1,627,945        1,627,945   
  

 

 

   

 

 

 

Total

     4,245,802        4,275,645   
  

 

 

   

 

 

 

12. MAJOR CUSTOMERS

For the three months ended December 31, 2012, revenues from two customers accounted for 28% and 13% of revenues, respectively, with no other single customer accounting for more than 10% of revenues. At December 31, 2012, accounts receivable from three customers accounted for 26%, 25% and 14% of total accounts receivable, respectively, with no other single customer accounting for more than 10% of the accounts receivable balance.

For the three months ended December 31, 2011, revenues from three customers accounted for 27%, 24% and 12% of revenues, respectively, with no other single customer accounting for more than 10% of revenues. At December 31, 2011, accounts receivable from two customers accounted for 56% and 17% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

 

9


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The discussion and analysis set forth below should be read in conjunction with the accompanying unaudited interim condensed consolidated financial statements and the related notes included under Item 1 of this Quarterly Report on Form 10-Q, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended September 30, 2012.

Forward Looking Statements

This report contains certain statements of a forward-looking nature relating to future events or future performance. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the only means of identifying forward-looking statements. Prospective investors are cautioned that such statements are only predictions and that actual events or results may differ materially. In evaluating such statements, prospective investors should specifically consider various factors identified in this report and any matters set forth under Part I, Item 1A (Risk Factors) of our Annual Report on Form 10-K, which could cause actual results to differ materially from those indicated by such forward-looking statements.

Overview

LRAD Corporation develops and delivers highly intelligible, directed acoustic products that beam, focus and control sound over short and long distances. By placing sound only where needed, we not only enhance many typical speaker applications, but we offer novel sound applications that conventional speakers cannot achieve. We offer a variety of directional sound products which meet a broad range of requirements from communicating with and deterring threats over distances up to 300 meters with our hand-held LRAD 100X to distances in excess of 3,500 meters with our LRAD 2000X. Since 1996, we have been at the forefront developing new acoustic innovations to project, focus, shape and control sound and we believe we have established a significant competitive advantage in our principal markets. Through increased focus and investment in worldwide sales and marketing activities our Long Range Acoustic Device® or LRAD® pioneered a new worldwide market for directional long-range acoustic hailing devices (“AHDs”).

In the quarter ended December 31, 2012, we had revenues of $2,980,107 compared to $3,611,635 in the quarter ended December 31, 2011. U.S. Defense spending continued to be slow, and is expected to remain slow through at least March 2013, when spending cuts or sequestration are expected to be addressed. We continue to pursue international opportunities, as well as new markets as a result of our new LRAD 360X and LRAD 2000X products. Gross margin for the quarter was 50% of net revenues, compared to 48% of net revenues for the quarter ended December 31, 2011. On a quarter over quarter basis, our revenues are expected to remain uneven.

Our LRAD-X product line uses directionality and focused acoustic output to clearly transmit critical information, instructions and warnings in excess of 3,500 meters. The LRAD-X product line features clear voice intelligibility and is available in a number of packages and form factors that meet the military’s stringent environmental requirements. Through the use of powerful voice commands and deterrent tones, large safety zones can be created while determining the intent and influencing the behavior of potential security threats. Our LRAD-X product line provides a complete range of systems from single user portable to permanently installed, remotely operated. Our LRAD products have been competitively selected over other commercially available systems by U.S. and several foreign militaries. Our LRAD-X product line includes the following:

 

   

LRAD 2000X—launched in fiscal 2012 to meet the requirements of larger security applications—is our largest and loudest acoustic hailing system and broadcasts highly intelligible voice communication that can be clearly heard and understood more than 3,500 meters away.

 

   

LRAD 1000X—selected by the U.S. Navy as its acoustic hailing device (“AHD”) for Block 0 of the Shipboard Protection System—can be manually operated to provide long distance hailing and warning with highly intelligible communication. This unit is available in both fully integrated and remotely operated electronics.

 

   

LRAD 500X—selected by the U.S. Navy and U.S. Army as their AHD for small vessels and vehicles—is lightweight and can be easily transported to provide security personnel long-range communications and a highly effective hailing and warning capability where needed.

 

   

LRAD 300X is a lightweight mid-range AHD developed for small vessels and manned and unmanned vehicles and aircraft. This unit is available in both fully integrated and remotely-operated electronics.

 

   

LRAD 100X is a self-contained, battery-powered, portable system designed for use in a variety of mass notification, law enforcement and commercial security applications. This unit is ideally suited for short-range perimeter security and communications.

 

10


   

LRAD-RX—selected by the U.S. Navy in a competitive bid as its AHD for Block 2 of the Shipboard Protection System—is our prescription for remotely controlled security. It enables system operators to detect and communicate with an intruder over long distances. LRAD-RX features an LRAD 1000X emitter head, integrated camera, high-intensity searchlight and a newly developed, robust, and Internet protocol-addressable full pan and tilt drive system for precise aiming and tracking. LRAD-RX can also be integrated with radar to provide automated intruder alerts. Because of its automated capabilities, LRAD-RX reduces manpower requirements and false alarms while providing an intelligent, cost-effective security solution.

 

   

LRAD 360X—launched in fiscal 2012—is designed with 360 degree directionality to provide features needed for mass notification and emergency warning capabilities. The LRAD 360X is targeted for market applications including campus, border and perimeter security, tsunami, hurricane and tornado warnings, bird safety and control, and asset protection.

Overall Business Outlook

We are experiencing positive response and increased acceptance of our products. We believe we have a solid technology and product foundation with our LRAD-X product line, and we have expanded our product line seeking to service new markets for greater business growth. We believe that we have strong market opportunities within the worldwide government and military sector, as well as increased commercial applications as a result of continued global threats to governments, commerce and law enforcement, and in wildlife preservation and control applications. Our selling network has expanded to include a number of key integrators and sales representatives within the United States and in a number of worldwide locations. However, we may continue to face challenges in fiscal 2013 due to extreme international economic and geopolitical conditions. A further and continued deterioration in financial markets and confidence in major economies could disrupt the operation of our business. We anticipate continued uncertainty with U.S. Military spending due to ongoing budget delays and expected spending reductions. We continue to pursue large business opportunities, but it is difficult to anticipate how long it will take to close these opportunities, or if they will ultimately result in product sales.

Critical Accounting Policies

We have identified a number of accounting policies as critical to our business operations and the understanding of our results of operations. These are described in our consolidated financial statements located in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended September 30, 2012. The impact and any associated risks related to these policies on our business operations is discussed below and throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations when such policies affect our reported and expected financial results.

The methods, estimates and judgments we use in applying our accounting policies, in conformity with generally accepted accounting principles in the U.S., have a significant impact on the results we report in our financial statements. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. The estimates affect the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.

Comparison of Results of Operations for the Three Months Ended December 31, 2012 and 2011

Revenues

The following table sets forth for the periods indicated certain items of our condensed consolidated statements of operations expressed in dollars and as a percentage of net revenues. The financial information and the discussion below should be read in conjunction with the condensed consolidated financial statements and notes contained in this report.

 

11


     Three months ended              
     December 31, 2012     December 31, 2011              
           % of Net            % of Net     Increase/(Decrease)  
     Amount     Revenue     Amount      Revenue     Amount     %  

Revenues:

             

Product sales

   $ 2,762,345        92.7   $ 3,545,053         98.2   $ (782,708     (22.1 %) 

Contract and other

     217,762        7.3     66,582         1.8     151,180        227.1
  

 

 

     

 

 

      

 

 

   
     2,980,107        100.0     3,611,635         100.0     (631,528     (17.5 %) 

Cost of revenues

     1,494,284        50.1     1,863,041         51.6     (368,757     (19.8 %) 
  

 

 

     

 

 

      

 

 

   

Gross profit

     1,485,823        49.9     1,748,594         48.4     (262,771     (15.0 %) 

Operating Expenses:

             

Selling, general and administrative

     1,172,475        39.3     1,056,559         29.3     115,916        11.0

Research and development

     421,921        14.2     381,318         10.5     40,603        10.6
  

 

 

     

 

 

      

 

 

   
     1,594,396        53.5     1,437,877         39.8     156,519        10.9
  

 

 

     

 

 

      

 

 

   

(Loss) income from operations

     (108,573     (3.6 %)      310,717         8.6     (419,290     (134.9 %) 

Other Income

     8,197        0.2     12,944         0.4     (4,747     (36.7 %) 
  

 

 

     

 

 

      

 

 

   

(Loss) income from operations before income taxes

     (100,376     (3.4 %)      323,661         9.0     (424,037     (131.0 %) 

Income tax expense

     —          0.0     9,715         0.3     9,715        (100.0 %) 
  

 

 

     

 

 

      

 

 

   

Net (loss) income

   $ (100,376     (3.4 %)    $ 313,946         8.7   $ (414,322     (132.0 %) 
  

 

 

     

 

 

      

 

 

   

The decrease in revenues was primarily due to a decrease in U.S. Military orders. Uncertainty on defense spending is expected to continue through at least March 2013 when spending cuts or sequestration are expected to be addressed. Contract and other revenue for the three months ended December 31, 2012 includes $197,031 for an annual maintenance agreement for units sold to a foreign military in fiscal 2011, that was not in place in the prior year. Due to the budgetary cycles of our customer base and the lack of established markets for our proprietary products, we expect continued uneven quarterly revenues in future periods.

At December 31, 2012, we had aggregate deferred revenue of $270,559 collected from a license agreement in advance of recognized revenue. This revenue component is subject to significant variability based on the timing, amount and recognition of new arrangements or payment terms.

Gross Profit

The decrease in gross profit in the quarter was primarily due to lower revenues and higher contracted annual maintenance costs compared to the costs for the first year warranty period related to a large foreign military sale in March 2011, offset by higher product margins as a percentage of sales due to favorable product mix.

Our products have varying gross margins, so product sales mix will materially affect gross profits. In addition, our margins vary based on the sales channels through which our products are sold in a given period. We continue to implement product updates and changes, including raw material and component changes that may impact product costs. With such product updates and changes we have limited warranty cost experience and estimated future warranty costs can impact our gross margins. We do not believe that historical gross profit margins should be relied upon as an indicator of future gross profit margins.

Selling, General and Administrative Expenses

Selling, general and administrative expenses reflected a $71,432 increase in non-cash share-based compensation expense as a result of new option grants and a $49,020 increase in legal fees related to the recent lawsuit, offset by $4,536 of spending reductions.

We incurred non-cash share-based compensation expenses allocated to selling, general and administrative expenses in the three months ended December 31, 2012 and 2011 of $189,831 and $118,399, respectively.

We may expend additional resources on the marketing and selling of our products in future periods as we identify ways to optimize potential opportunities. Commission expenses will fluctuate based on the nature of our sales. In addition, we expect legal expenses to increase at least through the second fiscal quarter due to the recent lawsuit and proxy matters. This may result in increased selling, general and administrative expenses in the future.

 

 

12


Research and Development Expenses

Research and development expenses reflected a $19,961 increase in product development costs and $21,422 due to increased travel costs for projects with current or prospective customers, offset by $780 of spending reductions.

Included in research and development expenses for the three months ended December 31, 2012 and 2011 was $12,248 and $14,006 of non-cash share-based compensation costs, respectively.

Each quarter, we review the ongoing value of our capitalized patent costs and in the third fiscal quarter we identified some of these assets as being associated with patents that are no longer consistent with our business strategy. As a result of this review, we sold a previously capitalized patent for its book value of $5,138 during the quarter ended December 31, 2012, compared to an impairment expense of $10,616 in the three months ended December 31, 2011.

Research and development costs vary period to period due to the timing of projects, the availability of funds for research and development and the timing and extent of the use of outside consulting, design and development firms. We continually improve our product offerings and we have further expanded the product line-up in 2012 and 2011 with new products, customizations and enhancements. Based on current plans, we expect research and development costs to continue in the current fiscal year on a basis comparable to the prior year.

(Loss) Income from Operations

The decrease in income from operations was primarily attributable to the decrease in revenues and gross margin, and an increase in operating expenses.

Other Income

During the three months ended December 31, 2012 we earned $4,747 less in interest income from our cash and cash equivalents balances compared to the three months ended December 31, 2011 as a result of a reduction in the interest rate in our interest bearing account.

Net (Loss) Income

The decrease in net income was primarily the result of lower revenues and gross margin in the quarter, and an increase in operating expenses. We did not recognize any income tax expense during the three months ended December 31, 2012, compared to $9,715 in the quarter ended December 31, 2011.

Liquidity and Capital Resources

Cash and cash equivalents at December 31, 2012 was $16,139,078, compared to $13,859,505 at September 30, 2012. The change in cash and cash equivalents was primarily the result of a reduction in accounts receivable from strong year-end shipments in September 30, 2012, partially offset by an increase in inventory during the quarter based on the forecasted requirements. Other than cash and cash equivalents and expected future cash flows from operating activities in subsequent periods, we have no other unused sources of liquidity at this time.

At December 31, 2012 and 2011, our working capital was $21,443,216 and $21,312,250, respectively. The increase was primarily a result of a decrease in accounts receivable, partially offset by an increase in inventory.

Principal factors that could affect our liquidity include:

 

   

ability to meet sales projections;

 

   

government spending levels;

 

   

introduction of competing technologies;

 

   

product mix and effect on margins;

 

   

ability to reduce current inventory levels; and

 

   

product acceptance in new markets.

 

13


Principal factors that could affect our ability to obtain cash from external sources include:

 

   

volatility in the capital markets; and

 

   

market price and trading volume of our common stock.

Based on our current cash position, and assuming currently planned expenditures and level of operations, we believe we have sufficient capital to fund operations for the next twelve months. However, we operate in a rapidly evolving and unpredictable business environment that may change the timing or amount of expected future cash receipts and expenditures. Accordingly, there can be no assurance that we may not be required to raise additional funds through the sale of equity or debt securities or from credit facilities. Additional capital, if needed, may not be available on satisfactory terms, or at all.

Cash Flows

Operating Activities

Our net cash provided by operating activities was $2,337,983 for the three months ended December 31, 2012, compared to $21,541 of cash used in operating activities for the three month ended December 31, 2011. Net cash provided by operating activities for the three months ended December 31, 2012 included a net loss of $100,376, increased by expenses not requiring the use of cash of $202,486, $3,249,384 from reduced accounts receivable, $113,452 from increased accrued and other liabilities and $131,777 from reduced prepaid expenses and other and prepaid expenses and other—noncurrent. Our net cash used in operating activities for the three months ended December 31, 2012 included $1,050,152 for increased inventories, $204,313 for reduced accounts payable and $4,275 for warranty settlements. Net cash used in operating activities during the three months ended December 31, 2011 included $313,946 of net income, decreased by expenses not requiring the use of cash of $399,590, $2,392,446 from accrued liabilities, which was primarily for payout of the fiscal year 2011 bonus payment, $443,881for decreased accounts payable and $366,924 for increased inventories. Our net cash provided by operating activities for the three months ended December 31, 2011 included $2,358,304 from reduced accounts receivable and $122,965 from reduced prepaid expenses and other and prepaid expenses and other—noncurrent.

At December 31, 2012, we had net accounts receivable of $2,268,710, compared to $5,517,894 in accounts receivable at September 30, 2012. The level of trade accounts receivable for the quarter ended December 31, 2012 represented approximately 70 days of revenue, compared to 90 days of revenue for the quarter ended September 30, 2012. Our receivables can vary significantly due to overall sales volumes and due to quarterly variations in sales and timing of shipments to and receipts from large customers and the timing of contract payments.

Investing Activities

We use cash in investing activities primarily for the purchase of tooling, computer equipment and software, and investment in new or existing patents. Cash used in investing activities for equipment and patents was $77,638 for the three months ended December 31, 2012 and $3,844 for the three months ended December 31, 2011. We anticipate some additional expenditure for equipment and patents during the balance of fiscal year 2013.

Financing Activities

In the three months ended December 31, 2012, we received $19,228 from the exercise of stock options. We did not receive any proceeds from financing activities in the three months ended December 31, 2011.

Recent Accounting Pronouncements

There were no adopted or pending recent accounting pronouncements that are expected to have a material impact on our condensed consolidated financial statements for the three months ended December 31, 2012.

 

Item 3. Qualitative and Quantitative Disclosures about Market Risk.

Interest Rate Risk

The Company’s interest income is sensitive to fluctuations in the general level of U.S. interest rates. Changes in U.S. interest rates affect the interest earned on the Company’s cash and cash equivalents. The Company’s exposure to market risk for changes in interest rates is minimal as a result of maintaining cash in savings accounts and short term money market accounts. The Company currently does not have any debt that could be subject to interest fluctuation or market risk.

 

14


Foreign Currency Risk

We consider our direct exposure to foreign exchange rate fluctuations to be minimal. Currently, all sales to customers and all arrangements with third-party manufacturers, with one exception, provide for pricing and payment in U.S. dollars, and, therefore, are not subject to exchange rate fluctuations. Increases in the value of the U.S. dollar relative to other currencies could make our products more expensive, which could negatively impact our ability to compete. Conversely, decreases in the value of the U.S. dollar relative to other currencies could result in our suppliers raising their prices to continue doing business with us. Fluctuations in currency exchange rates could affect our business in the future.

 

Item 4. Controls and Procedures.

We are required to maintain disclosure controls and procedures designed to ensure that material information related to us, including our consolidated subsidiaries, is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms.

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, we conducted an evaluation of our disclosure controls and procedures as such term is defined under Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of December 31, 2012.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting during our fiscal quarter ended December 31, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Our process for evaluating controls and procedures is continuous and encompasses constant improvement of the design and effectiveness of established controls and procedures and the remediation of any deficiencies, which may be identified during this process.

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings.

We may at times be involved in litigation in the ordinary course of business. We will also, from time to time, when appropriate in management’s estimation, record adequate reserves in our financial statements for pending litigation. On July 24, 2012, the Company was served with a complaint filed in the Delaware Court of Chancery by Iroquois Master Fund Ltd., a shareholder of the Company, against the Company’s board of directors, its Chief Executive Officer and Chief Financial Officer. The action is a purported derivative action which alleges breach of fiduciary duty and other claims against the individual defendants based on the issuance of stock options to them, which plaintiff alleges were granted in violation of the terms of the Company’s 2005 Equity Incentive Plan. The Company was also named in the action as a nominal defendant against which no recovery is sought. The plaintiff seeks rescission or repricing of the stock options at issue and other damages, purportedly on behalf of the Company. The defendants filed a motion to dismiss the complaint. Rather than oppose the motion, the plaintiff filed an amended complaint on November 19, 2012. Defendants filed a motion to dismiss the amended derivative complaint on December 17, 2012 and the motion is in the process of being fully briefed to the Court. The Company and the individual defendants seek dismissal of the complaint on the grounds that Plaintiff has failed to comply with Delaware law in filing the complaint. The individual defendants seek dismissal on the additional grounds that the Complaint fails to state a legal claim against them.

The Company has received a notice from Iroquois Master Fund Ltd. announcing its intention to nominate a slate of five directors to stand for election at the Company’s 2013 Annual Meeting of Stockholders. The Company’s newly formed Nominating and Corporate Governance Committee will review and consider the nominations, as well as qualified individuals who may be submitted by other stockholders to serve on the Company’s Board of Directors.

 

15


Item 1A. Risk Factors

As a Smaller Reporting Company as defined by Rule 12b-2 of the Exchange Act and in item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

 

Item 3. Defaults Upon Senior Securities.

None.

 

Item 4. Mine Safety Disclosures

Not Applicable.

 

Item 5. Other Information.

None.

 

Item 6. Exhibits

 

31.1   Certification of Thomas R. Brown, Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2   Certification of Katherine H. McDermott, Principal Financial Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1   Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Thomas R. Brown, Principal Executive Officer and Katherine H. McDermott, Principal Financial Officer.*
101.INS**   XBRL Instance Document
101.SCH**   SBRL Taxonomy Extension Schema Document
101.CAL**   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF**   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB**   XBRL Taxonomy Extension Label Linkbase Document
101.PRE**   XBRL Taxonomy Extension Presentation Linkbase Document

 

* Filed concurrently herewith.
** Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.

 

16